Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02578875 · ClinicalTrials.gov registry record

Evaluation of MiSeq for Microbial Identification in Specimens

A clinical trial, sponsored by National Institutes of Health Clinical Center (CC).

Completed
Registry status
65
Enrollment target

NCT02578875 is a clinical trial that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 65 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02578875 has completed, sponsored by National Institutes of Health Clinical Center (CC).

COMPLETED
Registry status
65 participants
Enrollment target

Study Summary

Background: Researchers are testing a new way to find out what causes infections in people in hospitals. Current techniques use chemical or biological tests on a person s samples. Samples are blood, tissue, stool, saliva, urine, etc. Researchers are testing new techniques that use a device called MiSeq. It can sequence all of the DNA (genetic material) in a sample. This may show microorganisms, such as bacteria, fungi, and viruses that cause infection. Researchers want to know if the new test works as well or better than current tests. They will do this by looking at about 250 samples. Objective: To test if MiSeq works as well as or better than current tests to identify microorganisms that cause infection. Eligibility: NIH patients whose samples have been sent to the Microbiology Service s lab for routine microbiologic testing. Design: Participants will consent to have samples they gave as part of their routine medical care used in the study. For those under age 18, a parent or legal guardian will consent.

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2015-11-12
Est. Completion 2019-09-30

What the Registry Record Tells You About NCT02578875

The ClinicalTrials.gov registry entry for NCT02578875 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02578875 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02578875 about?

NCT02578875 is a clinical study titled "Evaluation of MiSeq for Microbial Identification in Specimens". Background: Researchers are testing a new way to find out what causes infections in people in hospitals. Current techniques use chemical or biological tests on a person s samples. Samples are blood, tissue, stool, saliva, urine, etc. Researchers are testing new techniques that use a device called ...

What is the current status of trial NCT02578875?

This trial is currently completed. The enrollment target is 65 participants. The study started on 2015-11-12. Estimated completion is 2019-09-30.

Who is sponsoring clinical trial NCT02578875?

This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.